OTC Markets OTCPK - Delayed Quote USD
bioMérieux S.A. (BMXMF)
142.45
0.00
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 1 | 12 | 12 |
Avg. Estimate | 1.08B | 981M | 4.27B | 4.59B |
Low Estimate | 1.05B | 981M | 4.2B | 4.52B |
High Estimate | 1.1B | 981M | 4.34B | 4.65B |
Year Ago Sales | 965.2M | 936.7M | 3.98B | 4.27B |
Sales Growth (year/est) | 11.56% | 4.73% | 7.31% | 7.38% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BMXMF | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.40% | 7.54% | 14.08% |
Related Tickers
PANG.MC Pangaea Oncology, S.A.
1.7000
0.00%
603127.SS Joinn Laboratories(China)Co.,Ltd.
19.76
-0.20%
300347.SZ Hangzhou Tigermed Consulting Co., Ltd
51.76
-1.41%
TN8.DE Thermo Fisher Scientific Inc.
354.65
-0.94%
DIA.WA Diagnostyka S.A.
162.70
+1.40%
TN8.F Thermo Fisher Scientific Inc.
356.05
+0.01%
CHHL China Holdings, Inc.
0.0002
0.00%
BIOPOR.CO BioPorto A/S
1.3880
-0.14%
DIA.MI DiaSorin S.p.A.
93.32
-1.12%
NDRA ENDRA Life Sciences Inc.
3.4500
-5.48%